Advanced Search

Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2009 June;144(3) > Giornale Italiano di Dermatologia e Venereologia 2009 June;144(3):297-311

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014

Frequency: Bi-Monthly

ISSN 0392-0488

Online ISSN 1827-1820

 

Giornale Italiano di Dermatologia e Venereologia 2009 June;144(3):297-311

    REVIEWS

Italian position paper on urticaria

Pigatto P. D. 1, Marsili C. B. 1, Ayala F. 2, Depità O. 3, Gelmetti C. 4, Giannetti A. 5, Girolomoni G. 6, Vena G. A. 7, Cassano N. 7, Ayala F. 8

1 Department for Health Technologies IRCCS R. Galeazzi Hospital, Milan, Italy
2 Unit of Dermatology, Department of Systemic Pathology Federico II University, Naples, Italy
3 Immunology and Allergology Laboratory IDI-IRCCS, Rome, Italy
4 Dermatological Sciences Institute Policlinic Mangiagalli e Regina Elena, Milan, Italy
5 Department of Dermatology University of Modena and Reggio Emilia, Modena, Italy
6 Unit of Dermatology Department of Biomedical Sciences and Surgery University of Verona, Verona, Italy
7 Second Dermatological Clinic MIDIM, University of Bari, Bari, Italy
8 National Cancer Institute “G. Pascale”, Naples, Italy

The Italian Board on Urticaria has prepared a document focusing on the definition and classification of urticaria, taking into account the recent progress in identifying the causes, eliciting factors, and pathomechanisms of this disease. As urticaria has a profound impact on the quality of life, effective treatment is important. Therefore, specific treatment options for the management of urticaria are evaluated on the basis of the recent literature. Non-sedating H1 antihistamines are recommended as the first-line treatment as they have proven effective in several randomized double-blind controlled studies. Dosages higher than those recommended may be necessary in some cases. However, additional or alternative therapies may be required for different urticaria subtypes and in view of individual variations in the course of the disease and response to treatment. Immunosuppressive drugs such as corticosteroids are not recommended for long-term treatment due to unavoidable, severe adverse effects.

language: English


FULL TEXT  REPRINTS

top of page